Parrish Medical Center among the first to use new, leading-edge cardiovascular
FDA-Approved Impella CP Heart Pump™
TITUSVILLE, FLA. (Nov. 5, 2018) — Parrish Medical Center is now using the new, minimally invasive
technology called the Impella CP Heart Pump™. The medical device
was first used by PMC’s Cardiovascular team in August to reopen
blocked coronary arteries of a patient who had suffered three heart attacks
while in route to the emergency department.
The Impella™ is an advanced, percutaneous cardiac assist device that
pumps for the heart. It allows the heart to rest during stent placement
or balloon angioplasty. The device is inserted through a catheter in the
patient’s groin (femoral artery). This results in a much shorter
recovery for patients.
PMC’s first Impella™ patient was treated well under national
benchmarks of 90 minutes from arrival in the emergency room to the time
the coronary artery was opened (door-to-balloon time.) More importantly,
the patient experienced an excellent outcome and was able to return home
“It is extremely gratifying to us to be able to provide this medically
advanced cardiovascular treatment to our community,” said George
Mikitarian, Parrish Medical Center | Parrish Healthcare president/CEO.
“Use of the Impella™ allows more patients with severe heart
damage to receive the care they need close to home.”
According to Parrish Medical Center’s 2016 Community Needs Health
Assessment, more than 86 percent of adults in North Brevard report one
or more cardiovascular risk factors. Risk factors include being overweight,
smoking cigarettes, being physically inactive or having high blood pressure
The Florida Department of Health attribute 3 out of 10 deaths in Florida
to heart disease and it is the number one killer in the U.S.
While, to date, over 50,000 patients have been treated with Impella in
the United States, Impella is currently used in only 1 percent of percutaneous
coronary interventions. PMC’s Cardiovascular Services is at the
forefront of this lifesaving medical advancement.